Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
116
NMPA:116
Drug Approvals
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20249603
- Approval Date
- Dec 1, 2024
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20247155
- Approval Date
- Sep 29, 2024
NMPA
Oseltamivir Phosphate Capsules
- Product Name
- 磷酸奥司他韦胶囊
- Approval Number
- 国药准字H20244298
- Approval Date
- Aug 28, 2024
NMPA
Olopatadine Hydrochloride Eye Drops
- Product Name
- 盐酸奥洛他定滴眼液
- Approval Number
- 国药准字H20193095
- Approval Date
- Nov 8, 2023
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20234300
- Approval Date
- Oct 18, 2023
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20234301
- Approval Date
- Oct 18, 2023
NMPA
Lenvatinib Mesilate Capsules
- Product Name
- 甲磺酸仑伐替尼胶囊
- Approval Number
- 国药准字H20234192
- Approval Date
- Sep 28, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 12
- Next
Clinical Trials
No trials found
News
No news found